Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,341 to 1,360 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Critical Roles of METTL3 in Translation Regulation of Cancer. | Biomolecules | 2023 | 36830614 | PubTator, text mining | PubMed |
| m6A Modification-Association with Oxidative Stress and Implications on Eye Diseases. | Antioxidants (Basel) | 2023 | 36830067 | PubTator, text mining | PubMed |
| Identification and vitro verification of the potential drug targets of active ingredients of Chonglou in the treatment of lung adenocarcinoma based on EMT-related genes. | Front Genet | 2023 | 36824434 | PubTator, text mining | PubMed |
| The Effect of N6-Methyladenosine Regulators and m6A Reader YTHDC1-Mediated N6-Methyladenosine Modification Is Involved in Oxidative Stress in Human Aortic Dissection. | Oxid Med Cell Longev | 2023 | 36819785 | PubTator, text mining | PubMed |
| Pseudorabies virus exploits N6-methyladenosine modification to promote viral replication. | Front Microbiol | 2023 | 36819040 | PubTator, text mining | PubMed |
| Prognostic and immunological role of sulfatide-related lncRNAs in hepatocellular carcinoma. | Front Oncol | 2023 | 36816914 | PubTator, text mining | PubMed |
| Single-cell RNA datasets and bulk RNA datasets analysis demonstrated C1Q+ tumor-associated macrophage as a major and antitumor immune cell population in osteosarcoma. | Front Immunol | 2023 | 36814925 | PubTator, text mining | PubMed |
| The role of TNF-α in the fate regulation and functional reprogramming of mesenchymal stem cells in an inflammatory microenvironment. | Front Immunol | 2023 | 36814921 | PubTator, text mining | PubMed |
| A Prognostic Signature for Colon Adenocarcinoma Patients Based on m6A-Related lncRNAs. | J Oncol | 2023 | 36814559 | PubTator, text mining | PubMed |
| Promotion of the resistance of human oral epithelial cells to herpes simplex virus type I infection via N6-methyladenosine modification. | BMC Oral Health | 2023 | 36814204 | PubTator, text mining | PubMed |
| MALAT-1 regulates the AML progression by promoting the m6A modification of ZEB1. | Acta Biochim Pol | 2023 | 36812496 | PubTator, text mining | PubMed |
| Splice site m6A methylation prevents binding of DGCR8 to suppress KRT4 pre-mRNA splicing in oral squamous cell carcinoma. | PeerJ | 2023 | 36811004 | PubTator, text mining | PubMed |
| METTL14-dependent maturation of pri-miR-17 regulates mitochondrial homeostasis and induces chemoresistance in colorectal cancer. | Cell Death Dis | 2023 | 36810285 | PubTator, text mining | PubMed |
| Emerging roles of m6A RNA modification in cancer therapeutic resistance. | Exp Hematol Oncol | 2023 | 36810281 | PubTator, text mining | PubMed |
| Targeting RNA N6-methyladenosine to synergize with immune checkpoint therapy. | Mol Cancer | 2023 | 36810108 | PubTator, text mining | PubMed |
| m5C-dependent cross-regulation between nuclear reader ALYREF and writer NSUN2 promotes urothelial bladder cancer malignancy through facilitating RABL6/TK1 mRNAs splicing and stabilization. | Cell Death Dis | 2023 | 36806253 | PubTator, text mining | PubMed |
| Hypoxia induces alterations in tRNA modifications involved in translational control. | BMC Biol | 2023 | 36803965 | PubTator, text mining | PubMed |
| RBM15 suppresses hepatic insulin sensitivity of offspring of gestational diabetes mellitus mice via m6A-mediated regulation of CLDN4. | Mol Med | 2023 | 36803098 | PubTator, text mining | PubMed |
| Clinical and biological significance of RNA N6-methyladenosine regulators in Alzheimer disease. | Medicine (Baltimore) | 2023 | 36800593 | PubTator, text mining | PubMed |
| Gut microbiota: A novel and potential target for radioimmunotherapy in colorectal cancer. | Front Immunol | 2023 | 36798129 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=68